Transcription factor Efg1 contributes to the tolerance of Candida albicans biofilms against antifungal agents in vitro and in vivo

Journal of Medical Microbiology

Volumn 61, Issue 6, 2012, Pages 813-819

  Bink, Anna ^a   Govaert, Gilmer ^a   Vanden Bosch, Davy ^b   Kuchariková, Soňa ^a   Coenye, Tom ^b   Nelis, Hans ^b   van Dijck, Patrick ^a   Cammue, Bruno P A ^a   Thevissen, Karin ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b GHENT UNIVERSITY   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; CASPOFUNGIN; FLUCONAZOLE; MICONAZOLE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR EFG1; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIFUNGAL RESISTANCE; ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; BIOFILM; CANDIDA ALBICANS; CANDIDIASIS; CONTROLLED STUDY; DRUG ACCUMULATION; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; PRIORITY JOURNAL; RAT; STRAIN DIFFERENCE; WILD TYPE;

ANIMALS; ANTIFUNGAL AGENTS; BIOFILMS; CANDIDA ALBICANS; DNA-BINDING PROTEINS; DRUG RESISTANCE, FUNGAL; FUNGAL PROTEINS; GENE DELETION; MICONAZOLE; MICROBIAL SENSITIVITY TESTS; RATS; TRANSCRIPTION FACTORS;

EID: 84861139227     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.041020-0     Document Type: Article

References (38)

1. Bink, A., Govaert, G., François, I. E., Pellens, K., Meerpoel, L., Borgers, M., Van Minnebruggen, G., Vroome, V., Cammue, B. P. & Thevissen, K. (2010). A fungicidal piperazine-1-carboxamidine induces mitochondrial fission-dependent apoptosis in yeast. FEMS Yeast Res 10, 812-818.
2. Bink, A., Vandenbosch, D., Coenye, T., Nelis, H., Cammue, B. P. & Thevissen, K. (2011). Superoxide dismutases are involved in Candida albicans biofilm persistence against miconazole. Antimicrob Agents Chemother 55, 4033-4037.
3. CLSI (2008). Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeast; Approved Standard, M27-A3. Wayne, PA: Clinical and Laboratory Standards Institute.
4. Davis-Hanna, A., Piispanen, A. E., Stateva, L. I. & Hogan, D. A. (2008). Farnesol and dodecanol effects on the Candida albicans Ras1-cAMP signalling pathway and the regulation of morphogenesis. Mol Microbiol 67, 47-62.
5. François, I. E. J. A., Cammue, B. P. A., Borgers, M., Ausma, J., Dispersyn, G. D. & Thevissen, K. (2006). Azoles: mode of antifungal action and resistance development. Effect of miconazole on endogenous reactive oxygen species production in Candida albicans. Antiinfect Agents Med Chem 5, 3-13.
6. François, I. E., Bink, A., Vandercappellen, J., Ayscough, K. R., Toulmay, A., Schneiter, R., van Gyseghem, E., Van den Mooter, G., Borgers, M. & other authors (2009). Membrane rafts are involved in intracellular miconazole accumulation in yeast cells. J Biol Chem 284, 32680-32685.
7. Gillum, A. M., Tsay, E. Y. & Kirsch, D. R. (1984). Isolation of the Candida albicans gene for orotidine-59-phosphate decarboxylase by complementation of S. cerevisiae ura3 and E. coli pyrF mutations. Mol Gen Genet 198, 179-182.
8. Giusani, A. D., Vinces, M. & Kumamoto, C. A. (2002). Invasive filamentous growth of Candida albicans is promoted by Czf1p-dependent relief of Efg1p-mediated repression. Genetics 160, 1749-1753.
9. Jain, P., Akula, I. & Edlind, T. (2003). Cyclic AMP signaling pathway modulates susceptibility of Candida species and Saccharomyces cerevisiae to antifungal azoles and other sterol biosynthesis inhibitors. Antimicrob Agents Chemother 47, 3195-3201.
10. Katragkou, A., Chatzimoschou, A., Simitsopoulou, M., Dalakiouridou, M., Diza-Mataftsi, E., Tsantali, C. & Roilides, E. (2008). Differential activities of newer antifungal agents against Candida albicans and Candida parapsilosis biofilms. Antimicrob Agents Chemother 52, 357-360.
11. 22-desaturase, and inhibition by azole antifungal agents. J Biol Chem 272, 9986-9988.
12. Kuchariková, S., Tournu, H., Holtappels, M., Van Dijck, P. & Lagrou, K. (2010). In vivo efficacy of anidulafungin against mature Candida albicans biofilms in a novel rat model of catheter-associated candidiasis. Antimicrob Agents Chemother 54, 4474-4475.
13. Kuchariková, S., Tournu, H., Lagrou, K., Van Dijck, P. & Bujdáková, H. (2011). Detailed comparison of Candida albicans and Candida glabrata biofilms under different conditions and their susceptibility to caspofungin and anidulafungin. J Med Microbiol 60, 1261-1269.
14. Kuhn, D. M., George, T., Chandra, J., Mukherjee, P. K. & Ghannoum, M. A. (2002a). Antifungal susceptibility of Candida biofilms: unique efficacy of amphotericin B lipid formulations and echinocandins. Antimicrob Agents Chemother 46, 1773-1780.
15. Kuhn, D. M., Chandra, J., Mukherjee, P. K. & Ghannoum, M. A. (2002b). Comparison of biofilms formed by Candida albicans and Candida parapsilosis on bioprosthetic surfaces. Infect Immun 70, 878- 888.
16. Kyle, A. A. & Dahl, M. V. (2004). Topical therapy for fungal infections. Am J Clin Dermatol 5, 443-451.
17. Lachke, S. A., Srikantha, T. & Soll, D. R. (2003). The regulation of EFG1 in white-opaque switching in Candida albicans involves overlapping promoters. Mol Microbiol 48, 523-536.
18. Lamfon, H., Porter, S. R., McCullough, M. & Pratten, J. (2004). Susceptibility of Candida albicans biofilms grown in a constant depth film fermentor to chlorhexidine, fluconazole and miconazole: a longitudinal study. J Antimicrob Chemother 53, 383-385.
19. Lo, H. J., Köhler, J. R., DiDomenico, B., Loebenberg, D., Cacciapuoti, A. & Fink, G. R. (1997). Nonfilamentous C. albicans mutants are avirulent. Cell 90, 939-949.
20. Mateus, C., Crow, S. A., Jr & Ahearn, D. G. (2004). Adherence of Candida albicans to silicone induces immediate enhanced tolerance to fluconazole. Antimicrob Agents Chemother 48, 3358-3366.
21. Mermel, L. A., Farr, B. M., Sherertz, R. J., Raad, I. I., O'Grady, N., Harris, J. S. & Craven, D. E. (2001). Guidelines for the management of intravascular catheter-related infections. Clin Infect Dis 32, 1249-1272.
22. Mukherjee, P. K. & Chandra, J. (2004). Candida biofilm resistance. Drug Resist Updat 7, 301-309.
23. Nailis, H., Coenye, T., Van Nieuwerburgh, F., Deforce, D. & Nelis, H. J. (2006). Development and evaluation of different normalization strategies for gene expression studies in Candida albicans biofilms by real-time PCR. BMC Mol Biol 7, 25.
24. Peeters, E., Nelis, H. J. & Coenye, T. (2008). Comparison of multiple methods for quantification of microbial biofilms grown in microtiter plates. J Microbiol Methods 72, 157-165.
25. Perumal, P., Mekala, S. & Chaffin, W. L. (2007). Role for cell density in antifungal drug resistance in Candida albicans biofilms. Antimicrob Agents Chemother 51, 2454-2463.
26. Prasad, T., Hameed, S., Manoharlal, R., Biswas, S., Mukhopadhyay, C. K., Goswami, S. K. & Prasad, R. (2010). Morphogenic regulator EFG1 affects the drug susceptibilities of pathogenic Candida albicans. FEMS Yeast Res 10, 587-596.
27. Ramage, G., VandeWalle, K., López-Ribot, J. L. & Wickes, B. L. (2002). The filamentation pathway controlled by the Efg1 regulator protein is required for normal biofilm formation and development in Candida albicans. FEMS Microbiol Lett 214, 95-100.
28. Ramage, G., Mowat, E., Jones, B., Williams, C. & Lopez-Ribot, J. L. (2009). Our current understanding of fungal biofilms. Crit Rev Microbiol 35, 340-355.
29. Ricicová, M., Kuchariková, S., Tournu, H., Hendrix, J., Bujdáková, H., Van Eldere, J., Lagrou, K. & Van Dijck, P. (2010). Candida albicans biofilm formation in a new in vivo rat model. Microbiology 156, 909- 919.
30. Seneviratne, C. J., Jin, L. & Samaranayake, L. P. (2008). Biofilm lifestyle of Candida: a mini review. Oral Dis 14, 582-590.
31. Srikantha, T., Tsai, L. K., Daniels, K. & Soll, D. R. (2000). EFG1 null mutants of Candida albicans switch but cannot express the complete phenotype of white-phase budding cells. J Bacteriol 182, 1580-1591.
32. Stoldt, V. R., Sonneborn, A., Leuker, C. E. & Ernst, J. F. (1997). Efg1p, an essential regulator of morphogenesis of the human pathogen Candida albicans, is a member of a conserved class of bHLH proteins regulating morphogenetic processes in fungi. EMBO J 16, 1982-1991.
33. Tebarth, B., Doedt, T., Krishnamurthy, S., Weide, M., Monterola, F., Dominguez, A. & Ernst, J. F. (2003). Adaptation of the Efg1p morphogenetic pathway in Candida albicans by negative autoregula-tion and PKA-dependent repression of the EFG1 gene. J Mol Biol 329, 949-962.
34. Thevissen, K., Marchand, A., Chaltin, P., Meert, E. M. & Cammue, B. P. (2009). Antifungal carbazoles. Curr Med Chem 16, 2205-2211.
35. Vanden Bossche, H., Marichal, P., Willemsens, G., Bellens, D., Gorrens, J., Roels, I., Coene, M. C., Le Jeune, L. & Janssen, P. A. (1990). Saperconazole: a selective inhibitor of the cytochrome P-450-dependent ergosterol synthesis in Candida albicans, Aspergillus fumigatus and Trichophyton mentagrophytes. Mycoses 33, 335-352.
36. Vandenbosch, D., Braeckmans, K., Nelis, H. J. & Coenye, T. (2010). Fungicidal activity of miconazole against Candida spp. biofilms. J Antimicrob Chemother 65, 694-700.
37. Vinces, M. D., Haas, C. & Kumamoto, C. A. (2006). Expression of the Candida albicans morphogenesis regulator gene CZF1 and its regulation by Efg1p and Czf1p. Eukaryot Cell 5, 825-835.
38. Watamoto, T., Samaranayake, L. P., Jayatilake, J. A., Egusa, H., Yatani, H. & Seneviratne, C. J. (2009). Effect of filamentation and mode of growth on antifungal susceptibility of Candida albicans. Int J Antimicrob Agents 34, 333-339.